Several types of inhalers contain no steroids at all. These include short-acting rescue inhalers like albuterol, long-acting maintenance bronchodilators, anticholinergic inhalers, and even one over-the-counter option. Each works differently, but none rely on corticosteroids to open your airways.
Understanding which inhalers are steroid-free matters if you’re trying to avoid side effects associated with inhaled corticosteroids, or if you simply want to know what’s in the medication you’re breathing in every day.
Short-Acting Rescue Inhalers (SABAs)
The most familiar steroid-free inhaler is the short-acting beta-agonist, commonly known as a rescue inhaler. Albuterol (sold as Ventolin and ProAir) and levalbuterol (Xopenex) are the two main options in this category. They work by stimulating receptors on the smooth muscle lining your airways, causing those muscles to relax and the airways to widen. Relief typically starts within minutes and lasts four to six hours.
These inhalers are designed for quick relief during an asthma attack or a sudden episode of wheezing or chest tightness. They contain zero corticosteroids. However, current guidelines from the Global Initiative for Asthma (GINA) now recommend against using a rescue inhaler as your only asthma treatment. Regular use of a short-acting beta-agonist alone, even for just one to two weeks, can cause your airways to become less responsive to the medication over time and can actually increase airway sensitivity. The current recommendation is to pair rescue inhaler use with some form of inhaled corticosteroid for ongoing asthma management.
The most common side effects are hand tremor and a racing heartbeat. Skeletal muscle tremor is the most frequent dose-limiting side effect of this drug class. Cardiac arrhythmias can occur in rare cases but are generally mild.
Long-Acting Beta-Agonists (LABAs)
Long-acting beta-agonists like salmeterol (Serevent) and formoterol work through the same airway-relaxing mechanism as rescue inhalers but are designed to last 12 hours or more. They’re used as daily maintenance medications rather than for quick relief.
Here’s an important distinction: while these inhalers themselves contain no steroids, the FDA requires a boxed warning on all single-ingredient LABA products stating that using them alone to treat asthma, without an accompanying corticosteroid, is associated with an increased risk of asthma-related death. For this reason, LABAs are most commonly prescribed in combination inhalers that pair them with a steroid. If you’re using a standalone LABA inhaler, it’s almost certainly for COPD rather than asthma, or your doctor has you on a separate steroid inhaler alongside it.
Short-Acting Anticholinergic Inhalers (SAMAs)
Ipratropium bromide (sold as Atrovent) is the main short-acting anticholinergic inhaler. It works through a completely different mechanism than beta-agonists. Instead of directly relaxing airway muscles, it blocks a chemical messenger called acetylcholine that triggers the muscles to tighten in the first place. Think of it as turning off the signal that tells your airways to constrict. Effects last six to eight hours.
Ipratropium contains no steroids. It’s used primarily for COPD and is sometimes combined with albuterol in a single inhaler (Combivent), which is also steroid-free.
Long-Acting Anticholinergic Inhalers (LAMAs)
These are the longer-lasting versions of anticholinergic inhalers, and they’re a cornerstone of COPD treatment. The most well-known is tiotropium (Spiriva Respimat), which works for a full 24 hours on a single dose. Other options include aclidinium (Tudorza), umeclidinium (Incruse Ellipta), and glycopyrronium (Seebri).
All of these are completely steroid-free. They block the same receptors as ipratropium but with a much longer duration, making them suitable for once-daily or twice-daily maintenance dosing. Spiriva Respimat, for example, contains only tiotropium bromide as its active ingredient. These inhalers are intended for daily maintenance use in COPD and are not meant for treating sudden breathing emergencies.
Several steroid-free combination inhalers pair a LAMA with a LABA for enhanced bronchodilation. These include tiotropium/olodaterol (Stiolto Respimat), umeclidinium/vilanterol (Anoro Ellipta), and indacaterol/glycopyrronium (Utibron Neohaler). All open the airways through two complementary mechanisms without any corticosteroid component.
Cromolyn Sodium
Cromolyn sodium is a lesser-known steroid-free inhaled medication that works differently from all the bronchodilators above. Rather than relaxing airway muscles, it prevents certain immune cells from releasing the inflammatory substances that trigger asthma symptoms in the first place. It’s used as a preventive treatment before exposure to known triggers like exercise, cold air, pet dander, pollen, or dust mites.
The original brand name (Intal) is no longer on the market, though generic versions may still be available. Cromolyn is generally considered less effective than inhaled corticosteroids for long-term asthma control, which is why it’s fallen out of common use. But it remains an option for people who specifically need a non-steroidal preventive inhaler.
Over-the-Counter: Primatene Mist
Primatene Mist is the only FDA-approved over-the-counter asthma inhaler currently available in the United States. Its active ingredient is epinephrine (0.125 mg per spray), a powerful bronchodilator with no corticosteroid content. It’s approved for temporary relief of mild, intermittent asthma symptoms including wheezing, chest tightness, and shortness of breath.
The key word is “mild.” Primatene Mist is not a substitute for prescription asthma management, and epinephrine stimulates the entire body more broadly than albuterol does, which means more pronounced side effects on heart rate and blood pressure.
How Non-Steroid Inhalers Differ From Steroid Inhalers
The fundamental difference is what these medications target. Every steroid-free inhaler listed above works on the muscles or nerve signals that control airway width. They physically open your airways. Inhaled corticosteroids, by contrast, reduce the underlying inflammation that makes airways swollen, irritated, and overly reactive in the first place.
A landmark study in the New England Journal of Medicine demonstrated this clearly: adding an inhaled corticosteroid to a beta-agonist bronchodilator improved lung function by about 10% of predicted value within three months, while adding an anticholinergic bronchodilator produced no significant change. The corticosteroid also substantially reduced airway hyperresponsiveness, meaning the airways became less twitchy and reactive to triggers. The bronchodilator alone did not achieve this.
This is why steroid-free inhalers are excellent at relieving symptoms but generally don’t address the root cause of asthma. For COPD, the picture is somewhat different. Bronchodilators play a more central role, and not all COPD patients need inhaled steroids. Many people with COPD are well managed on steroid-free LAMA or LAMA/LABA combinations alone.
If you’re looking to avoid steroids entirely, the options exist, but the right choice depends heavily on whether you’re managing asthma or COPD, and how severe your condition is. For asthma specifically, current guidelines strongly favor including at least a low dose of inhaled corticosteroid in your treatment plan, using steroid-free rescue inhalers only for breakthrough symptoms rather than as your sole medication.